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OBJECTIVES The objectives of this study were to determine racial differences in mortality in a national
cohort of patients hospitalized with congestive heart failure (CHF) within a financially
“equal-access” healthcare system, the Veterans Health Administration (VA), and to examine
racial differences in patterns of healthcare utilization following hospitalization.
BACKGROUND To explain the observed paradox of increased readmissions and lower mortality in black
patients hospitalized with CHF, it has been postulated that black patients may have reduced
access to outpatient care, resulting in a higher number of hospital admissions for lesser disease
severity.
METHODS In a retrospective study of 4,901 black and 17,093 white veterans hospitalized with CHF in
153 VA hospitals, we evaluated mortality at 30 days and 2 years, and healthcare utilization in
the year following discharge.
RESULTS The risk-adjusted odds ratios (OR) for 30-day and 2-year mortality in black versus white
patients were 0.70 (95% confidence interval [CI] 0.60 to 0.82) and 0.84 (95% CI 0.78 to
0.91), respectively. In the year following discharge, blacks had the same rate of readmissions
as whites. Blacks had a lower rate of medical outpatient clinic visits and a higher rate of urgent
care/emergency room visits than whites, although these differences were small.
CONCLUSIONS In a system where there is equal access to healthcare, the racial gap in patterns of healthcare
utilization is small. The observation of better survival in black patients after a CHF
hospitalization is not readily explained by differences in healthcare utilization. (J Am Coll
Cardiol 2004;43:778–84) © 2004 by the American College of Cardiology Foundationo
t
s
h
s
o
h
a
i
w
fi
w
i
p
T
o
h
M
P
s
v
n
r
S
ilacks have a higher prevalence of congestive heart failure
CHF) than do whites (1). Hospitalizations for CHF, as
ell as readmissions after an initial hospitalization, have also
een reported to be more common in black patients (2–4).
owever, some of the studies evaluating patients hospital-
zed with CHF have demonstrated better short-term sur-
ival in black patients compared with white patients (2,5–7).
See page 785
his survival advantage has been observed for both in-
ospital mortality and mortality up to one year after
ischarge. The reasons for this paradox of increased hospi-
alizations in the face of a better survival are not clear. One
eason suggested has been differential access to medical care
y race. It has been postulated that reduced access to
utpatient care in blacks (because of a greater proportion
eing uninsured and unable to pay for care) may result in a
igher number of hospitalizations for lesser disease severity
2). None of these studies has been able to link the use of
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f the Department of Veterans Affairs.
Manuscript received June 9, 2003; revised manuscript received September 2, 2003,Cccepted October 27, 2003.utpatient care with hospital use and mortality to explore
his possibility (2,5,7).
The Veterans Health Administration (VA) healthcare
ystem offers a unique opportunity to address this issue. VA
ealthcare utilization databases can be linked with vital
tatus data to create patient-specific longitudinal inpatient,
utpatient, and mortality records. In addition, the VA
ealthcare system is a nationwide, federally funded “equal-
ccess” healthcare system. Access to care is not restricted by
nsurance status or an inability to pay for care. Physicians
ho provide care in this system are salaried and lack
nancial incentives to provide or deny care to patients (8).
The main objectives of our study were twofold. The first
as to determine racial differences in short-term and
ntermediate-term mortality in a large, diverse cohort of
atients hospitalized for CHF in the VA healthcare system.
he second was to examine racial differences in the patterns
f healthcare utilization in these patients after the index
ospitalization.
ETHODS
atient population. We performed a retrospective cohort
tudy of veterans hospitalized with CHF. We identified all
eterans who were admitted to 153 acute-care VA hospitals
ationwide with a principal diagnosis of CHF (diagnosis
elated group [DRG] 127) between October 1, 1997, and
eptember 30, 1999. To control for stage of CHF we
ncluded only those patients who had a first admission for
HF, as defined by no VA hospitalizations for CHF in the
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March 3, 2004:778–84 Race and Heart Failurerior two years. We excluded patients for whom race could
ot be identified in the database (n  300) and restricted
ur analyses to black and non-Hispanic white patients (n 
1,994). For evaluation of short-term mortality we used the
ntire cohort of 21,994 patients. However, to examine
ealthcare utilization and intermediate-term mortality fol-
owing discharge, the cohort included only patients dis-
harged alive after the index admission (n  21,003).
ata sources. We linked three national VA databases: the
A Patient Treatment Files (PTF), which contain abstracts
n all patients discharged from VA hospitals; the VA
utpatient Clinic files, which contain records for all services
rovided to outpatients by VA staff; and the VA Beneficiary
dentification and Records Locator Subsystem death file.
he VA death file contains death records regardless of the
lace of death and captures information on 90% to 95% of
eceased veterans (9). In addition, death was identified from
he PTF. All the databases contain encrypted patient
dentifiers and can be linked to create person-specific
ongitudinal utilization and vital status records.
utcome and utilization variables. Both short-term and
ntermediate-term mortality were outcome measures.
hort-term mortality was defined as mortality within 30
ays of the date of the index admission. Intermediate-term
ortality was measured at one and two years following
ischarge in the cohort of patients that were discharged alive
fter the index admission.
The VA healthcare utilization was measured for the year
ollowing discharge. Rates of medical clinic visits and urgent
are/emergency room visits were used as measures of out-
atient care. The rate of all-cause readmissions and bed-
ays of care as well as the rate of medical readmissions were
sed as measures of inpatient care (10,11). The all-cause
eadmission rate is the average number of discharges that a
atient had in the year following discharge. The bed-day
ate is the average number of days spent in the hospital for
ny admissions per patient-year of follow-up after dis-
harge. Similar rates were calculated for medical readmis-
ions, that is, all admissions excluding those with a DRG for
sychiatry or surgery. Both the bed-day rate and the
eadmission rate measure the intensity of hospital use in a
ohort. Avoiding hospitalizations or shortening hospitaliza-
ions will both reduce the bed-days of care, but only the
ormer will reduce the readmission rate. Therefore, the
Abbreviations and Acronyms
CHF  congestive heart failure
DRG  diagnosis related group
ER  emergency room
HF  heart failure
ICD-9-CM  International Classification of Diseases-
Ninth Revision-Clinical Modification
PTF  patient treatment files
VA  Veterans Health Administrationed-day rate will be the more sensitive indicator of changes In hospital use in a system. Medical clinic visits occurred
hen a patient received outpatient care in a general medical
r medical subspecialty clinic.
Person time was used as the denominator for the rates.
ll rates were calculated per patient-year of follow-up. In
he year after discharge, the number of days spent in the
ospital was deducted from the days “at risk” for readmis-
ion and outpatient visits.
tatistical analysis and risk adjustment. The Student t
est was used to test for baseline differences in continuous
ariables and the chi-square test was used for categorical
ariables. Unadjusted survival curves were generated by the
aplan-Meier method, and survival was compared between
roups using the log-rank test. Logistic regression was used
o calculate the risk-adjusted odds of mortality for black
atients relative to white patients. To account for correla-
ions among patients treated at the same hospital and for
imilar practice patterns among hospitals located in a
articular geographic area, we used hierarchical mixed
odels. Patients were nested within hospitals and hospitals
ere nested within Census Bureau divisions. Risk adjust-
ent was performed by controlling simultaneously for
ovariates that included demographic variables (age, gender,
ncome, and marital status, with marital status and income
sed as measures of social support) and comorbidities. Using
nternational Classification of Diseases-Ninth Revision-
linical Modification (ICD-9-CM) diagnosis codes, a
anel of clinicians selected 21 comorbid conditions a priori
s potentially important in influencing mortality and utili-
ation in patients with CHF. The list of all comorbidities
nd the ICD-9-CM codes used to define the comorbidities
s provided in the Appendix. A log transformation of the
tilization measures was performed, as the distribution of
he number of clinic visits and hospitalizations was right-
kewed. Again, hierarchical mixed models, as described
arlier, were used to calculate risk-adjusted rates of utiliza-
ion per patient-year of follow-up and to compare these
ates between black and white patients. All values of p 
.01 were considered statistically significant. Statistical
nalysis was performed using SAS software 8.2 (SAS
able 1. Baseline Characteristics
Characteristics
Blacks
(N  4,901)
Whites
(N  17,093)
ge (yrs)* 66.6  0.2 70.5  0.1†
ender (% male) 98.9 98.3
ncome  $10,000/yr (%) 44.2 37.5†
arried (%) 39.1 51.9†
ypertension (%) 72.8 65.9†
schemic heart disease (%) 48.4 63.2†
iabetes (%) 40.6 42.8†
hronic lung disease (%) 33.3 42.7†
enal insufficiency (%) 21.8 18.5†
eripheral vascular disease (%) 15.2 22.4†
erebrovascular disease (%) 12.4 15.1†
Mean  SEM. †p value 0.01 for comparisons between black and white patients.nstitute, Cary, North Carolina).
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Race and Heart Failure March 3, 2004:778–84ESULTS
aseline characteristics of the study population. The
ohort included 4,901 (22.3%) black patients and 17,093
77.7%) white patients. Table 1 displays the baseline char-
cteristics in the two groups. More than 98% of the cohort
embers were men. Black patients were on average four
ears younger than white patients. A higher proportion of
lack patients had an annual income $10,000 and were
nmarried compared with white patients. Furthermore,
lack patients were more likely to have a history of hyper-
ension and renal insufficiency, whereas white patients were
ore likely to have ischemic heart disease, chronic lung
isease, diabetes, peripheral vascular disease, and cerebro-
ascular disease. Overall, the burden of comorbidities was
igher in white patients (Fig. 1). A greater proportion of
hite patients (49%) had 5 comorbidities as compared
ith black patients (41.4%), and a greater proportion of
lack patients (31.2%) had 2 comorbidities as compared
ith white patients (24.2%, p  0.0005).
ortality. During the index admission, 160 (3.3%) black
atients and 831 (4.9%) white patients died (p  0.0005).
igure 1. Number of comorbidities by race in patients with heart failure.
 0.0005 for comparison of the number of comorbidities by race.Figure 2. Kaplan-Meier sut 30 days after admission, the crude mortality was 227
4.6%) in blacks and 1,253 (7.3%) in whites (p  0.0005).
t one year after discharge, there were 949 deaths (20%) in
lack patients and 4,190 deaths (25.8%) in white patients
p  0.0005), and at two years there were 1,444 deaths
30.5%) and 6,087 deaths (37.5%), respectively (p 0.001).
igure 2 shows the Kaplan-Meier survival curves in black
nd white patients.
As shown in Table 2, the risk-adjusted mortality at all
ime points was also significantly lower in black patients
hen compared with white patients. The risk-adjusted odds
atio (OR) for mortality at 30 days after admission for black
ompared with white patients was 0.7 (95% CI 0.6 to 0.82).
t one and two years after discharge, the ORs were 0.82
95% CI 0.75 to 0.9) and 0.84 (95% CI 0.78 to 0.91),
espectively. The survival advantage was consistent across
ubgroups of patients by age, presence of hypertension,
resence of coronary artery disease, and presence of diabetes
Table 3).
ealthcare utilization. Risk-adjusted rates of healthcare
tilization in the year following discharge are shown in
able 4. After discharge, on average, black patients
eceived a lesser number of medical outpatient clinic
isits (8.6  0.4) as compared with white patients (9.6 
.3, p  0.001), though this difference was relatively
mall. In contrast, black patients received somewhat more
f their outpatient care through the emergency room/
rgent care clinic, with an average of 0.4 more urgent
are/emergency room (ER) visits in black patients com-
ared with white patients, per patient-year of follow up
p  0.001). However, the readmission rates for all-cause
eadmissions as well as for medical readmissions, and the
ed days of care per patient-year of follow-up were
imilar in black and white patients (Table 4).rvival curves by race.
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March 3, 2004:778–84 Race and Heart FailureISCUSSION
n the VA healthcare system, a system designed to provide
qual access to healthcare, irrespective of the ability to pay,
e found significant differences in short-term and
ntermediate-term mortality by race, but relatively small
ifferences in patterns of healthcare utilization, after a
ospitalization for CHF. Our results demonstrate a lower
hort-term and intermediate-term mortality in black pa-
ients with a first hospitalization for CHF as compared with
hite patients. One explanation for this finding is that black
atients may have a lesser overall disease burden or be at an
arlier stage of disease progression at the time of admission
ompared with white patients. In our study, black patients
ere younger and had fewer comorbidities compared with
hite patients, consistent with a lesser overall burden of
isease. We have attempted to account for differences in
isease burden by risk-adjustment of the outcomes for
ifferences in age and several comorbidities, as well as by the
ethod of selection of our cohort. Because the first hospi-
alization for a chronic condition often signifies that the
isease has become more severe, we selected our cohort
sing an index admission that was the first admission for
HF in a two-year period. In addition, we examined
ortality across various subgroups and found that the
urvival advantage was consistent in both younger and older
lack patients as well as in those with coronary artery
Table 2. Risk-Adjusted Mortality by Race
Short-term (30-day) mortality after admission
One-year mortality after discharge
Two-year mortality after discharge
p  0.001.
CI  confidence interval; OR  risk-adjusted odds ratio
able 3. Mortality by Race in Selected Subgroups
30-Day Mortality
Crude Mortality (%)
OR (9Black White
ge (yrs)
65 3.26 4.13 0.81 (0
65–74 4.09 6.90 0.61 (0
75 7.05 9.82 0.70 (0
AD
Present 4.47 7.26 0.67 (0
Absent 4.78 7.47 0.71 (0
ypertension
Present 4.40 6.60 0.70 (0
Absent 5.25 8.75 0.67 (0
iabetes
Present 4.57 6.56 0.77 (0
Absent 4.68 7.91 0.65 (0AD  coronary artery disease. Other abbreviations as in Table 2.isease, diabetes, or hypertension. In spite of these mea-
ures, we may have been unable to account for all differences
n clinical severity, and it is possible that the differences in
ortality may be attributable to unmeasured residual con-
ounding.
An alternative explanation for the higher mortality in
hites would be that the care received by white patients was
ystematically inferior to that received by black patients.
owever, extensive data in the literature on racial disparities
n healthcare would not support that explanation. For
xample, two previous studies that evaluated patients ad-
itted for CHF to non-VA hospitals showed worse quality
f care for black patients compared with white patients
12,13). We were unable to directly evaluate racial differ-
nces in the process of care and medication use for the
atients. However, findings from recent studies within the
A have suggested that the process of care delivered to
ospitalized VA patients may not differ significantly by race
14,15). Most recently, Gordon et al. (14) evaluated process
f hospital care by race in 2,582 patients discharged from 12
A hospitals. They found that inpatient treatment and
ischarge care were similar among black, white, and His-
anic patients admitted with one of three medical diag-
oses, including CHF. In addition, Petersen et al. (15)
ecently showed that at the time of discharge from the VA,
rescription of medications in patients with acute myocar-
Risk-Adjusted Mortality
OR
(95% CI)Blacks Whites
4.5% 6.4% 0.70*
(0.60–0.82)
20.6% 23.9% 0.82*
(0.75–0.90)
32.0% 35.9% 0.84*
(0.78–0.91)
aring mortality in black versus white patients.
2-Year Mortality
I)
Crude Mortality (%)
OR (95% CI)Black White
.11) 23.02 25.68 0.95 (0.82–1.11)
.80) 30.50 36.98 0.76 (0.67–0.87)
.89) 40.35 45.83 0.82 (0.72–0.93)
.83) 34.23 39.50 0.86 (0.78–0.96)
.88) 26.90 33.90 0.81 (0.72–0.92)
.85) 31.13 36.89 0.85 (0.77–0.93)
.88) 28.66 38.57 0.81 (0.70–0.94)
.98) 31.84 38.29 0.80 (0.71–0.91)
.79) 29.51 36.82 0.87 (0.78–0.96)comp5% C
.59–1
.47–0
.56–0
.54–0
.57–0
.59–0
.51–0
.61–0
.53–0
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Race and Heart Failure March 3, 2004:778–84ial infarction, including beta-blockers, was similar for black
nd white patients. In addition, a recent study of Medicare
eneficiaries has shown that the quality of care did not differ
y race, including prescription of angiotensin-converting
nzyme inhibitors or angiotensin receptor blockers at dis-
harge after a heart failure (HF) hospitalization (16). In our
tudy, an indirect parameter to judge process of care during
he hospitalization is the average length of stay during an
dmission. If a significant number of black patients were
eing discharged prematurely, it would be expected that the
verage number of days spent in the hospital for the same
umber of admissions would be lower in blacks compared
ith whites, but this was not found to be the case. No
ublished studies have evaluated process of care and adher-
nce to guidelines by race in outpatients with CHF within
he VA system. This remains an area for future research.
ther explanations for better survival in black patients,
ncluding better social support or better socioeconomic
tatus, are also not supported by the findings of our study or
hose of others (17,18).
Furthermore, the etiology, pathophysiology, cardiovascu-
ar adaptation to cardiac injury, and manifestations of CHF
ay be different in black patients compared with white
atients, leading to a relatively higher need for hospitaliza-
ion at an earlier stage in the disease. For example, multiple
tudies including ours have shown that blacks with CHF are
ounger at presentation and are more likely to have hyper-
ension and left ventricular hypertrophy with a lower fre-
uency of coronary artery disease (19–22). Hypertensive
eart disease associated with a greater susceptibility to
odium retention in black patients may make this ethnic
roup more prone to sudden symptomatic pulmonary con-
estion with resultant use of hospitalization at earlier stages
f disease progression (7), but with better survival after that
ndex hospitalization. In addition, it may be expected that
ypertensive heart disease is associated with a higher pro-
ortion of diastolic HF in black patients and may therefore
ave a better prognosis. However, review of prior studies of
atient cohorts with CHF, which include both diastolic and
ystolic HF and which have documented the racial distri-
ution of patients, have not demonstrated a higher propor-
ion of black patients as having diastolic HF compared with
able 4. Risk-Adjusted Rates of Healthcare Utilization
Blacks
(n  4,741)
Whites
(n  16,262)
ates of outpatient visits to a
principal medical clinic
8.57  0.36 9.56  0.33*
ates of ER/urgent care visits 2.00  0.09 1.61  0.08*
ates of all-cause readmissions 1.64  0.04 1.68  0.03
ll-cause bed-days of care rates 12.40  0.77 12.23  0.69
ates of medical readmissions 1.44  0.04 1.45  0.03
alues are rates per year of patient follow-up and are expressed as mean  SEM.
p  0.001 for comparisons between black and white patients. Differences in
eadmission rates and bed-days of care were not significant between the two groups.
ER  emergency room.hite patients, and one study has even demonstrated a sigher percentage of systolic HF in black compared with
hite patients (23–30).
The finding that that the black patient cohort had better
urvival, appears to be in contrast to the accepted belief that
lack patients with CHF present at a later course in their
isease and have a worse prognosis compared with white
atients (1,31). However, most studies or statistics docu-
enting poorer outcomes in blacks with CHF have not
een restricted to hospitalized patients, but have included
he overall population with HF, either in clinical trials or in
he community (1,19). It should be emphasized that studies
ike ours that demonstrate better outcomes in black patients
ave studied hospitalized patients. Earlier non-VA studies
ave suggested that black patients hospitalized with CHF
ay represent a group with a lesser severity of illness owing
o different patterns of hospitalization by race (2,6,7). Black
atients may have had reduced access to outpatient care
hrough lack of insurance or an inability to pay for medical
are, and they may therefore receive a higher proportion of
heir medical care in an in-hospital setting (2,6). However,
his explanation is not supported by our study. The VA
ystem is a financially “equal-access” healthcare system. In
ddition, in our study, black patients did not receive a larger
hare of their care in a hospitalized setting, as demonstrated
y a similar rate of readmissions and similar number of days
pent in the hospital for medical care by race.
The findings of lower short-term mortality after admission
n blacks have been shown in a previous study of patients
ospitalized in VA hospitals with a number of different
edical diagnoses, including CHF (5). Jha et al. (5) found a
ower short-term mortality (at 30 days and 6 months) in
ospitalized black VA beneficiaries. Our study adds to their
tudy by evaluating longer term survival, as well as by exam-
ning patterns of healthcare utilization after the index admis-
ion. Our study demonstrated that the survival advantage in
lack patients in the short-term is maintained over time, at
east for two years of follow-up.
In a setting designed to provide financially equitable
ccess to care, we found that both black and white patients
ith CHF received relatively high-intensity outpatient care.
n the year following discharge, even though black patients
ad a fewer number of medical clinic visits as compared
ith white patients, the difference was relatively small. This
ppeared to have been offset by a slightly higher number of
isits to the ER/urgent care by the black patients. Further-
ore, within the VA setting, the overall outpatient care
outpatient care and urgent care/emergency room visits)
eceived by black patients appeared to be successful in
eeping the pattern of readmissions similar to the white
atients. As noted earlier, this is in contrast to the non-VA
etting, where most studies have shown an increased num-
er of rehospitalizations in black patients with CHF (2–4).
he overall increased access to care in the outpatient setting
ay have reduced the racial differences in in-hospital use of
ervices observed in non-VA studies. The reasons for the
mall differences observed in patterns of outpatient service
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March 3, 2004:778–84 Race and Heart Failuretilization with the somewhat lower rates of medical clinic
isits and higher rates of urgent care/ER visits could not be
ddressed by our study. They may include physician, health-
are system, or patient factors such as racial disparities or
ias in the scheduling of follow-up visits or nonadherence to
cheduled visits. Lesser social support, as demonstrated by a
igher proportion of black patients being unmarried and
aving a lower income, may make black patients less able to
dhere to regularly scheduled visits. In addition, one should
lso consider racial differences in patient-physician interac-
ion and differences in the way racially diverse groups of
atients accept the recommendations of physicians as a
ossible explanation for our findings (32–35). Interventions
esigned to make physicians more sensitive to cultural
iversity and bias and to influence the patient-physician
nteraction may be important in improving and eliminating
acial disparities in the patterns of healthcare utilization in
oth VA and non-VA settings (36).
tudy limitations. The present study was based on retro-
pective analyses of VA administrative databases. Such data
o not include sufficient detail on clinical severity of illness
n CHF. However, in another study using detailed clinical
ata obtained by chart review, we examined outcomes in
lack and white patients admitted to a tertiary care VA
ospital over a similar time period. Analysis of that data
howed that black race was an independent predictor of
mproved survival after hospitalization during follow-up of
p to 36 months (29). In addition, it is important to point
ut that we only measured healthcare utilization within the
A. Veterans age 65 years and older are eligible to receive
are either in the VA system or in the private sector under
edicare. Of note, 80% of the patients in our cohort are
65 years. To examine this issue, our co-authors (C.M.A.,
.J.P., N.P.W.) have evaluated VA and Medicare (non-
A) bed-days of care rates in fiscal years 1997 and 1998, in
national cohort of CHF patients 65 years who had an
ndex admission at a VA hospital for CHF. They found that
on-VA, Medicare-reimbursed bed-days of care constituted
9% and 21% of bed-days of care per patient-year for
atients in their cohort during 1997 and 1998, respectively
37). When analyzed by race for fiscal years 1997 and 1998,
edicare bed-days accounted for 21% and 23% of the
ed-days of care per patient-year in black patients and 19%
nd 21% of the bed-days of care per patient-year in white
atients, respectively (Dr. Carol Ashton, unpublished data,
ay 2003). Therefore, the data do not support excessive
on-VA, Medicare-reimbursed hospital use by white veter-
ns as compared with black patients with CHF. However,
e cannot rule out differential utilization of non-VA,
edicare-reimbursed outpatient services by race in this
atient population. Database studies linking VA files to
edicare outpatient utilization files are needed to address
his issue. In addition, we do not have data on non-VA use
n patients under 65 years of age, but such patients form less
han 20% of our cohort. Also, these patients generally haveery limited access to non-VA care, as the great majority of
A beneficiaries are underinsured or uninsured (38).
Another limitation of this study is that men accounted for
lmost 99% of patients in the cohort, consistent with the
emographics of hospitalized VA beneficiaries. The results,
herefore, cannot be generalized to women, especially be-
ause there are gender differences in HF outcomes that may
nteract with race (39).
onclusions. In the VA healthcare system, a system de-
igned to provide financially “equal access” to care for all
nrolled patients, the racial gap in patterns of healthcare
tilization in patients with CHF is small. The observation
f better survival in black patients after a hospitalization for
HF is not readily explained by differences in healthcare
tilization and needs further evaluation.
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PPENDIX
or a list of all the comorbidities and the ICD-9-CM
odes used to define the comorbidities, please see the
arch 3, 2004, issue of JACC at www.cardiosource.com/
acc.html.
